Genetic testing for sudden infant death
Part of Genetic & congenital clinical trials.
This study looks for gene changes that might be linked to sudden unexpected infant death. It compares the DNA of babies who died suddenly with DNA from their parents, to find possible inherited causes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was between 0 and 2 years old and died suddenly and unexpectedly
- Your child's death is recorded in the French SUDI (sudden unexpected death in infant) national registry, and their tissue samples are stored in the study's biobank
- Both biological parents are willing to give a blood sample and sign a consent form
- Neither your child nor either biological parent had a known genetic, metabolic, or syndromic condition at the time of death
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for children or adults with neurodevelopmental conditions and unusual physical features, where standard genetic tests haven't found a cause. Researchers will use RNA and DNA sequencing to look for hidden genetic explanations, which could guide better care.
This registry collects information (and sometimes DNA) from families affected by sudden unexplained death, to help researchers learn possible underlying causes. If you qualify, you may be contacted about participating in a DNA study or completing family information.
This study looks at the DNA of young people who died suddenly without a clear cause, to find inherited heart conditions. If a genetic cause is found, close family members can be tested to learn their own risk and get preventive care.
This study offers genetic testing for infants under 18 months who are in intensive care with certain health problems that may be genetic. The goal is to find a genetic cause quickly, which could guide care and treatment.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
This study uses advanced DNA and RNA testing to find genetic causes of serious illness in newborns. It aims to give families a faster, more accurate diagnosis and better care.
Hear when a new Sudden Infant Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.